Export 29 results:
Filters: Author is Brenda L. Plassman [Clear All Filters]
Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimer's and dementia. 2011;7(1):74-9.
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimer's and dementia. 2011;7(1):94-109.
The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. Journal of Alzheimer's disease. 2009;17(4):807-15..
The effect of spousal caregiving and bereavement on depressive symptoms. Aging & Mental Health. 2008;12(1):100 - 107. doi:10.1080/13607860801936631..
Prevalence of Depression among Older Americans: the Aging, Demographics and Memory Study. International Psychogeriatrics. 2009;21(5):879-88..
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimer's and Dementia. 2011;7(1):35-52.
Parental Education and Late-life Dementia in the United States. Journal of Geriatric Psychiatry and Neurology. 2009;22(1):71-80.
Cognitive performance and informant reports in the diagnosis of cognitive impairment and dementia in African Americans and whites. Alzheimer's and Dementia. 2009;5(6):445-453.
Incidence of dementia and cognitive impairment not dementia in the United States. Annals of Neurology. 2011. doi:10.1002/ana.22362.
Prevalence of Cognitive Impairment Without Dementia in the United States. Annals of Internal Medicine. 2008;148(6):427-434.
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study. Neuroepidemiology. 2007;29(1-2):125-132.
Identification of Dementia: Agreement among National Survey Data, Medicare Claims, and Death Certificates. Health Services Research. 2008;43(1):313-26..
Prevalence of Neuropsychiatric Symptoms and Their Association with Functional Limitations in Older Adults in the United States: The Aging, Demographics, and Memory Study. Journal of the American Geriatrics Society. 2010;58(2):330-337..
Neuropsychiatric Symptoms and the Risk of Institutionalization and Death: The Aging, Demographics, and Memory Study. Journal of the American Geriatrics Society. 2011;59(3):473-481..
Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study. Neurobiology of Aging. 2019;80:173-186. doi:10.1016/j.neurobiolaging.2018.10.028..
Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. Alzheimers Res Ther. 2010;2(3):19.
The Aging, Demographics and Memory Study: Study Design and Methods. Neuroepidemiology. 2005;25:181-191.
The association between neighborhood socioeconomic status, cardiovascular and cerebrovascular risk factors, and cognitive decline in the Health and Retirement Study (HRS). Aging & Mental Health. Forthcoming. doi:10.1080/13607863.2019.1594169.
Factors associated with cognitive evaluations in the United States. Neurology. 2015;84(1):64 - 71. doi:10.1212/WNL.0000000000001096.
Trajectories of depressive symptoms and oral health outcomes in a community sample of older adults. International Journal of Geriatric Psychiatry. 2016;31(1):83-91. doi:10.1002/gps.4292..
Neighborhoods, sleep quality, and cognitive decline: Does where you live and how well you sleep matter?. Alzheimer's & Dementia. 2018;14(4):454-461. doi:10.1016/j.jalz.2017.10.007.
Aging, Demographics and Memory Study (ADAMS): Sample Design, Weighting and Analysis for ADAMS. Ann Arbor, Michigan: Institute for Social Research, University of Michigan; 2009.
Effect of APOE and CD33 on cognitive decline. Plos One. 2015;10(6). doi:10.1371/journal.pone.0130419..
Differences in Functional Impairment Across Subtypes of Dementia. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2010;65A(4):434-441..
Functional limitations in older adults who have cognitive impairment without dementia. Journal of geriatric psychiatry and neurology. 2013..